Clínica Baviera, S.A. (LON:0GWJ)
London
· Delayed Price · Currency is GBP · Price in EUR 33.50
-0.10 (-0.30%)
At close: Feb 21, 2025
Clínica Baviera Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 447 | 325 | 252 | 290 | 206 | 198 | Upgrade
|
| Market Cap Growth | 64.53% | 28.95% | -13.07% | 40.94% | 4.26% | -0.48% | Upgrade
|
| Enterprise Value | 472 | 326 | 254 | 303 | 237 | 238 | Upgrade
|
| Last Close Price | 27.70 | 19.25 | 14.52 | 14.13 | 10.14 | 9.59 | Upgrade
|
| PE Ratio | 14.48 | 10.42 | 9.64 | 12.62 | 16.49 | 18.22 | Upgrade
|
| PS Ratio | 2.29 | 1.65 | 1.43 | 1.99 | 1.87 | 1.87 | Upgrade
|
| PB Ratio | 6.80 | 4.06 | 4.16 | 6.24 | 5.12 | 7.57 | Upgrade
|
| P/TBV Ratio | 12.30 | 5.09 | 5.44 | 8.86 | 7.84 | 14.88 | Upgrade
|
| P/FCF Ratio | 15.91 | 10.67 | 7.23 | 9.53 | 9.73 | 14.38 | Upgrade
|
| P/OCF Ratio | 9.18 | 6.49 | 5.33 | 7.38 | 7.31 | 9.18 | Upgrade
|
| EV/Sales Ratio | 2.26 | 1.66 | 1.44 | 2.08 | 2.15 | 2.26 | Upgrade
|
| EV/EBITDA Ratio | 8.10 | 5.66 | 5.04 | 6.75 | 7.96 | 8.95 | Upgrade
|
| EV/EBIT Ratio | 11.12 | 7.52 | 6.82 | 9.13 | 13.33 | 15.31 | Upgrade
|
| EV/FCF Ratio | 15.60 | 10.71 | 7.27 | 9.93 | 11.18 | 17.30 | Upgrade
|
| Debt / Equity Ratio | 0.72 | 0.51 | 0.70 | 0.93 | 1.22 | 1.74 | Upgrade
|
| Debt / EBITDA Ratio | 0.87 | 0.71 | 0.84 | 0.96 | 1.65 | 1.71 | Upgrade
|
| Debt / FCF Ratio | 1.69 | 1.35 | 1.21 | 1.42 | 2.31 | 3.30 | Upgrade
|
| Asset Turnover | 1.34 | 1.38 | 1.40 | 1.36 | 1.10 | 1.58 | Upgrade
|
| Inventory Turnover | - | 49.67 | 47.16 | 47.03 | 45.24 | 57.04 | Upgrade
|
| Quick Ratio | 0.80 | 1.18 | 1.01 | 1.00 | 0.91 | 0.34 | Upgrade
|
| Current Ratio | 0.80 | 1.28 | 1.09 | 1.06 | 0.97 | 0.40 | Upgrade
|
| Return on Equity (ROE) | 45.36% | 45.73% | 48.72% | 55.70% | 37.33% | 43.32% | Upgrade
|
| Return on Assets (ROA) | 16.98% | 19.03% | 18.47% | 19.36% | 11.14% | 14.55% | Upgrade
|
| Return on Capital (ROIC) | 23.34% | 24.46% | 23.53% | 23.90% | 13.48% | 18.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 33.99% | 37.52% | 38.47% | 40.29% | 22.39% | 24.80% | Upgrade
|
| Earnings Yield | 6.91% | 9.59% | 10.38% | 7.93% | 6.07% | 5.49% | Upgrade
|
| FCF Yield | 6.77% | 9.37% | 13.83% | 10.50% | 10.28% | 6.95% | Upgrade
|
| Dividend Yield | 3.13% | 7.08% | 7.94% | 6.12% | 4.88% | - | Upgrade
|
| Payout Ratio | 67.91% | 36.26% | 56.89% | 62.62% | - | 73.92% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | - | -0.01% | 0.01% | 0.01% | Upgrade
| |
| Total Shareholder Return | 3.13% | 7.08% | 7.94% | 6.11% | 4.88% | 0.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.